Department of Molecular Endocrinology, National Institute for Research in Reproductive Health, Indian Council of Medical Research, Mumbai, 400012, India.
P.D, Hinduja National Hospital and Medical Research Centre, Mumbai, 400004, India.
Reprod Sci. 2022 Mar;29(3):836-848. doi: 10.1007/s43032-021-00775-0. Epub 2021 Nov 8.
The cumulus-oocyte complex (COC) matrix plays a critical role in the ovulation and fertilization process and a major predictor of oocyte quality. Proteomics studies of follicular fluid showed differential expression of COC matrix proteins in women with polycystic ovary syndrome (PCOS), indicating altered COC matrix in these women. In the present study, we aimed to understand COC matrix gene induction in humans and its probable dysfunction in women with PCOS. Animal studies have shown that amphiregulin (AREG) and growth differentiation factor-9 (GDF-9) are important in the induction of COC matrix genes which are involved in cumulus expansion. The effects of AREG and GDF-9 on expression of tumor necrosis factor alpha induced protein 6 (TNFAIP6) and hyaluronan synthase 2 (HAS2) on human cumulus granulosa cells (CGCs) and murine COC expansion were evaluated. Further time-dependent effects of growth factor supplementation on these gene expressions in CGCs from PCOS and control women were compared. Follicular fluid from PCOS showed reduced COC matrix expansion capacity, using murine COCs. Expression of COC matrix genes TNFAIP6 and HAS2 were significantly reduced in CGCs of PCOS. Treatment of CGCs with AREG and GDF-9 together induced expression of both these genes in controls and could only restore HAS2 but not TNFAIP6 expression in PCOS. Our results suggest that the reduced potential of follicular fluid to support COC expansion, altered expression of structural constituents, and intrinsic defects in granulosa cells of women with PCOS may contribute to the aberrant COC organization and expansion in PCOS, thus affecting fertilization.
卵丘-卵母细胞复合体(COC)基质在排卵和受精过程中起着关键作用,是卵母细胞质量的主要预测指标。对卵泡液的蛋白质组学研究表明,多囊卵巢综合征(PCOS)患者的 COC 基质蛋白表达存在差异,表明这些患者的 COC 基质发生了改变。本研究旨在了解人类 COC 基质基因的诱导及其在 PCOS 患者中的可能功能障碍。动物研究表明,表皮生长因子(AREG)和生长分化因子 9(GDF-9)在诱导 COC 基质基因中起重要作用,这些基因参与卵丘扩张。评估了 AREG 和 GDF-9 对肿瘤坏死因子-α诱导蛋白 6(TNFAIP6)和透明质酸合酶 2(HAS2)在人卵丘颗粒细胞(CGC)和鼠 COC 扩张中的表达的影响。进一步比较了生长因子补充对 PCOS 和对照组妇女 CGC 中这些基因表达的时间依赖性影响。使用鼠 COC 显示,PCOS 的卵泡液 COC 基质扩张能力降低。PCOS 的 CGC 中 COC 基质基因 TNFAIP6 和 HAS2 的表达明显降低。AREG 和 GDF-9 联合处理可诱导对照组 CGC 中这两种基因的表达,但仅能恢复 PCOS 中 HAS2 的表达,而不能恢复 TNFAIP6 的表达。我们的结果表明,PCOS 患者卵泡液支持 COC 扩张的潜力降低、结构成分表达改变以及颗粒细胞内在缺陷,可能导致 PCOS 中 COC 结构和扩张异常,从而影响受精。